Copyright
©The Author(s) 2021.
World J Clin Oncol. Aug 24, 2021; 12(8): 581-608
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.581
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.581
Table 3 Eighth edition of the tumor, node, metastasis classification for mesothelioma
T | Primary tumor | N | Regional lymph nodes |
Tx | Primary tumor cannot be assessed | Nx | Regional lymph nodes cannot be assessed |
T0 | No evidence of primary tumor | N0 | No regional lymphnodemetastases |
T1 | Tumor limited to the ipsilateral parietal pleura with or without involvement of visceral pleuralmediastinal pleuradiaphragmatic pleura | N1 | Metastases in the ipsilateral bronchopulmonary, hilar or mediastinal (including the internal mammary, peridiaphragmatic, pericardial fat pad or intercostal lymph nodes) lymph node) |
T2 | Tumor involving each of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic and visceral pleura) with at least one of the following features: Involvement of diaphragmatic muscle. Extension of tumor from visceral pleura into the underlying pulmonary parenchyma | N2 | Metastases in the contralateral mediastinal, ipsilateral or contralateral supraclavicular lymph nodes |
T3 | Locally advanced but potentially resectable tumor. Tumor involving all of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, visceral pleura) with at least one of the following features: Involvement of endothoracic fascia; Extension into the mediastinal fat; Non-transmural involvement of the pericardium; Solitary, completely resectable focus of Tumor extending into the soft tissues of the chest wall | M | Distant metastasis |
T4 | Locally advanced technically unresectable tumor. Tumor involving all of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic and visceral pleura) with at least one of the following features: Diffuse extension or multifocal masses of tumor in the chest wall, with or without associated rib destruction; Direct transdiaphragmatic extension of tumor to peritoneum; Direct extension of tumor to the contralateral pleura; Direct extension of tumor to mediastinal organs; Tumor extending through to the internal surface of the pericardium with or without pericardial effusion, or tumor involving the myocardium | M0 | No distant metastasis |
M1 | Distant metastasis present |
- Citation: Luna J, Bobo A, Cabrera-Rodriguez JJ, Pagola M, Martín-Martín M, Ruiz MÁG, Montijano M, Rodríguez A, Pelari-Mici L, Corbacho A, Moreno M, Couñago F. GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma. World J Clin Oncol 2021; 12(8): 581-608
- URL: https://www.wjgnet.com/2218-4333/full/v12/i8/581.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i8.581